AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19217105 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage in addition to prescribed laxatives
Number of subjects: 60
Study 19217105 — intervention group
Group type: COMPARATOR
Intervention: Laxatives according to earlier prescriptions
Number of subjects: 60
Study 17441849 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine (PVP‐I) 100 mg/ml
Number of subjects: 30
Study 17441849 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine (PVP‐I) 70 mg/ml
Number of subjects: 30
Study 17441849 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate 50 mg/ml
Number of subjects: 30
Study 17441849 — intervention group
Group type: COMPARATOR
Intervention: Deionized water (control)
Number of subjects: 30
Study 15259298 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine medical testing (12-lead electrocardiogram, complete blood count, serum glucose measurements)
Number of subjects: 1025
Study 15259298 — intervention group
Group type: COMPARATOR
Intervention: Selective medical testing (no routine tests unless new or worsening medical problem)
Number of subjects: 1025
Study 15259298 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine medical testing
Number of subjects: 1025
Study 15259298 — intervention group
Group type: COMPARATOR
Intervention: Selective medical testing
Number of subjects: 1025
Study 12361204 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day for 4 weeks
Number of subjects: 40
Study 12361204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 10516870 — intervention group
Group type: EXPERIMENTAL
Intervention: trichlormethiazide
Number of subjects: 33
Study 10516870 — intervention group
Group type: EXPERIMENTAL
Intervention: nicardipine
Number of subjects: 33
Study 10516870 — intervention group
Group type: EXPERIMENTAL
Intervention: alacepril
Number of subjects: 33
Study 7711988 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10-20 mg
Number of subjects: 25
Study 7711988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 2791449 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral verapamil (120 mg) and propranolol (80 mg) combined
Number of subjects: 8
Study 2791449 — intervention group
Group type: COMPARATOR
Intervention: Oral verapamil (120 mg)
Number of subjects: 8
Study 2791449 — intervention group
Group type: COMPARATOR
Intervention: Oral propranolol (80 mg)
Number of subjects: 8
Study 780040 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethosuximide given once daily
Number of subjects: 20
Study 780040 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethosuximide given 3 times daily
Number of subjects: 20
Study 780040 — intervention group
Group type: EXPERIMENTAL
Intervention: Single daily dose regimen
Number of subjects: 20
Study 30478686 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic washout
Number of subjects: 63
Study 30478686 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous drainage
Number of subjects: 63
Study 30478686 — intervention group
Group type: COMPARATOR
Intervention: Open drainage
Number of subjects: 63
Study 28789780 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (IncoA) injection
Number of subjects: 30
Study 24570287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (N=292)
Number of subjects: 292
Study 24570287 — intervention group
Group type: COMPARATOR
Intervention: Control schools (N=300)
Number of subjects: 292
Study 23930743 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg for patients ≤65 years; 5 mg for patients >65 years)
Number of subjects: 154
Study 23930743 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST, 12 total sessions)
Number of subjects: 154
Study 23930743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 21561899 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise training
Number of subjects: 196
Study 21561899 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based exercise training
Number of subjects: 196
Study 18565522 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 34
Study 18565522 — intervention group
Group type: COMPARATOR
Intervention: Diane(35) Diario
Number of subjects: 34
Study 16982785 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg extended-release ciprofloxacin
Number of subjects: 12
Study 16982785 — intervention group
Group type: COMPARATOR
Intervention: 500 mg levofloxacin
Number of subjects: 12
Study 15327344 — intervention group
Group type: EXPERIMENTAL
Intervention: Mozart's Eine Kleine Nachtmusik
Number of subjects: 63
Study 15327344 — intervention group
Group type: EXPERIMENTAL
Intervention: New Age Serenity Suite
Number of subjects: 63
Study 15327344 — intervention group
Group type: COMPARATOR
Intervention: Popular recreational magazines
Number of subjects: 63
Study 11377154 — intervention group
Group type: COMPARATOR
Intervention: Propofol 6 microg/mL
Number of subjects: 44
Study 11377154 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 8 microg/mL
Number of subjects: 44
Study 9406491 — intervention group
Group type: EXPERIMENTAL
Intervention: Green prescription (written exercise advice)
Number of subjects: 25
Study 9406491 — intervention group
Group type: COMPARATOR
Intervention: Verbal advice alone
Number of subjects: 25
Study 8566633 — intervention group
Group type: EXPERIMENTAL
Intervention: etodolac 400 mg
Number of subjects: 52
Study 8566633 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen 500 mg b.i.d.
Number of subjects: 52
Study 8566633 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study 2598769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodiol 250 mg/day
Number of subjects: 0
Study 2598769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodiol 500 mg/day
Number of subjects: 0
Study 2598769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodiol 750 mg/day
Number of subjects: 0
Study 2598769 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodiol administration in patients with initial serum bilirubin levels > 2 mg/dl
Number of subjects: 0
Study 31774382 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative stereotype toward women
Number of subjects: 77
Study 31774382 — intervention group
Group type: COMPARATOR
Intervention: Nullified-stereotype
Number of subjects: 77
Study 31774382 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 77
Study 30804309 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 54
Study 30804309 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate followed by RMGIC
Number of subjects: 54
Study 30804309 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (Dycal)
Number of subjects: 54
Study 28486043 — intervention group
Group type: COMPARATOR
Intervention: Azacitidine (75 mg/m2/day on days 1 to 7 of a 28-day cycle)
Number of subjects: 277
Study 28486043 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine plus Lenalidomide (10 mg/day on days 1 to 21)
Number of subjects: 277
Study 28486043 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine plus Vorinostat (300 mg twice daily on days 3 to 9)
Number of subjects: 277
Study 26190726 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon (operator)
Number of subjects: 321
Study 26190726 — intervention group
Group type: COMPARATOR
Intervention: 1st assistant
Number of subjects: 321
Study 23158882 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV10 3+1 schedule
Number of subjects: 47369
Study 23158882 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV10 2+1 schedule
Number of subjects: 47369
Study 23158882 — intervention group
Group type: COMPARATOR
Intervention: Control group (hepatitis vaccines)
Number of subjects: 47369
Study 23158882 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined PHiD-CV10 infant cohorts
Number of subjects: 47369
Study 23158882 — intervention group
Group type: COMPARATOR
Intervention: Control cohorts
Number of subjects: 47369
Study 23158882 — intervention group
Group type: COMPARATOR
Intervention: Catch-up cohorts (Control group)
Number of subjects: 47369
Study 21756034 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing delivered by counselors with workshop‐only training
Number of subjects: 296
Study 21756034 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing delivered by counselors with workshop training followed by peer group supervision
Number of subjects: 296
Study 21756034 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 296
Study 19402342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine hydrochloride
Number of subjects: 0
Study 19402342 — intervention group
Group type: COMPARATOR
Intervention: Internal standard (loratadine)
Number of subjects: 0
Study 16986136 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical instillation of 100 ml capsaicin diluted in glucidic solvent (CG)
Number of subjects: 33
Study 16986136 — intervention group
Group type: COMPARATOR
Intervention: Glucidic solvent alone (SG)
Number of subjects: 33
Study 12763986 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Terms Version 3
Number of subjects: 10
Study 12763986 — intervention group
Group type: COMPARATOR
Intervention: Read Codes 5 byte set
Number of subjects: 10
Study 10904458 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepared meal plan
Number of subjects: 302
Study 9253565 — intervention group
Group type: EXPERIMENTAL
Intervention: Berman intubating airway
Number of subjects: 65
Study 9253565 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovassapian intubating airway
Number of subjects: 65
Study 7794292 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 2
Study 7794292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 3504357 — intervention group
Group type: EXPERIMENTAL
Intervention: In situ saphenous vein
Number of subjects: 100
Study 3504357 — intervention group
Group type: COMPARATOR
Intervention: Reversed saphenous vein
Number of subjects: 100
Study 29856793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermatoscope-acquired green channel intensity
Number of subjects: 64
Study 29856793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermatoscope-acquired blue channel intensity
Number of subjects: 64
Study 29856793 — intervention group
Group type: COMPARATOR
Intervention: Directly applied pressure and dermatoscope without filter
Number of subjects: 64
Study 29856793 — intervention group
Group type: COMPARATOR
Intervention: Dermatoscope equipped with Wratten No. 11 filter
Number of subjects: 64
Study 27731748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab plus fludarabine and cyclophosphamide (OFA + FC)
Number of subjects: 365
Study 27731748 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine and cyclophosphamide (FC)
Number of subjects: 365
Study 26298642 — intervention group
Group type: EXPERIMENTAL
Intervention: Proficiency-based progression using the knot tester (Group C, n = 16)
Number of subjects: 94
Study 26298642 — intervention group
Group type: COMPARATOR
Intervention: Standard training (Group A, n = 14)
Number of subjects: 94
Study 26298642 — intervention group
Group type: COMPARATOR
Intervention: Workstation practice (Group B, n = 14)
Number of subjects: 94
Study 26298642 — intervention group
Group type: COMPARATOR
Intervention: Experienced surgeons (n = 30)
Number of subjects: 94
Study 26298642 — intervention group
Group type: COMPARATOR
Intervention: Faculty (n = 20)
Number of subjects: 94
Study 26298642 — intervention group
Group type: COMPARATOR
Intervention: Postgraduate year 4 or 5 residents (n = 44)
Number of subjects: 94
Study 23597357 — intervention group
Group type: EXPERIMENTAL
Intervention: Home fecal immunochemical tests (FITs) offered during influenza vaccination clinics
Number of subjects: 6235
Study 23597357 — intervention group
Group type: COMPARATOR
Intervention: No FIT offered (control group)
Number of subjects: 6235
Study 23597357 — intervention group
Group type: EXPERIMENTAL
Intervention: Home fecal immunochemical tests (FITs) offered during influenza vaccination clinics (per protocol analysis)
Number of subjects: 6235
Study 23597357 — intervention group
Group type: COMPARATOR
Intervention: No FIT offered (control group, per protocol analysis)
Number of subjects: 6235
Study 21692400 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia Outreach Service (DEMOS) provided to 7 intervention facilities
Number of subjects: 320
Study 21692400 — intervention group
Group type: COMPARATOR
Intervention: Control group of 13 facilities without DEMOS
Number of subjects: 320
Study 18175062 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual blockade (ACEI + ARB)
Number of subjects: 86
Study 18175062 — intervention group
Group type: COMPARATOR
Intervention: Single blockade (ARB)
Number of subjects: 86
Study 16455629 — intervention group
Group type: EXPERIMENTAL
Intervention: 89SrCl2 therapy
Number of subjects: 42
Study 16455629 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 42
Study 12701977 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (40 mg/m2) concurrent with radiotherapy
Number of subjects: 39
Study 11013775 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (5 mg) injected periarticularly
Number of subjects: 32
Study 11013775 — intervention group
Group type: COMPARATOR
Intervention: Saline injected periarticularly (Control)
Number of subjects: 32
Study 8805740 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (0.140 mg/kg/min for 6 minutes)
Number of subjects: 54
Study 8805740 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole (0.142 mg/kg/min for 4 minutes)
Number of subjects: 54
Study 1621888 — intervention group
Group type: EXPERIMENTAL
Intervention: Proguanil (200 mg/day) combined with dapsone (4 mg or 12.5 mg/day)
Number of subjects: 438
Study 1621888 — intervention group
Group type: COMPARATOR
Intervention: Pyrimethamine/dapsone (12.5 mg and 100 mg/week)
Number of subjects: 438
Study 1621888 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg/day)
Number of subjects: 438
Study 6150856 — intervention group
Group type: EXPERIMENTAL
Intervention: S3341 (15 and 25 micrograms/kg)
Number of subjects: 13
Study 6150856 — intervention group
Group type: EXPERIMENTAL
Intervention: S3341 (2 mg)
Number of subjects: 13
Study 6150856 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.1 and 0.2 mg)
Number of subjects: 13
Study 6150856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 30895745 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 19
Study 29634402 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagining a visual stimulus
Number of subjects: 24
Study 29634402 — intervention group
Group type: COMPARATOR
Intervention: Actual visual stimulus exposure
Number of subjects: 24
Study 24793364 — intervention group
Group type: EXPERIMENTAL
Intervention: Prize-based contingency management (CM)
Number of subjects: 81
Study 24793364 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 81
Study 24793364 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional CM schedule
Number of subjects: 81
Study 24793364 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced CM schedule
Number of subjects: 81
Study 23107588 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on training by student tutors (ST)
Number of subjects: 30
Study 23107588 — intervention group
Group type: COMPARATOR
Intervention: Hands-on training by expert cardiographer (EC)
Number of subjects: 30
Study 23107588 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of improvement between groups
Number of subjects: 30
Study 19731013 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg for 8 weeks
Number of subjects: 30
Study 19731013 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole 1 mg for 8 weeks
Number of subjects: 30
Study 19731013 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study 17606534 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral, attenuated monovalent G1[P8] human rotavirus vaccine (10^4.7 infectious units)
Number of subjects: 405
Study 17606534 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral, attenuated monovalent G1[P8] human rotavirus vaccine (10^5.2 infectious units)
Number of subjects: 405
Study 17606534 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral, attenuated monovalent G1[P8] human rotavirus vaccine (10^5.8 infectious units)
Number of subjects: 405
Study 17606534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study 16221141 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight image enhancement procedures
Number of subjects: 25
Study 16221141 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoothing, shading correction, delineate and grey‐level normalization
Number of subjects: 25
Study 12198070 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway ProSeal (PLMA)
Number of subjects: 120
Study 12198070 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal tube airway (LTA)
Number of subjects: 120
Study 9990748 — intervention group
Group type: EXPERIMENTAL
Intervention: MPI-DLV
Number of subjects: 733
Study 7774139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum antibiotics (group 1)
Number of subjects: 219
Study 7774139 — intervention group
Group type: EXPERIMENTAL
Intervention: White blood cell count (WBC)
Number of subjects: 219
Study 7774139 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine GBS LA test
Number of subjects: 219
Study 2321774 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 micrograms in 10 ml normal saline)
Number of subjects: 50
Study 2321774 — intervention group
Group type: COMPARATOR
Intervention: Epidural normal saline (10 ml)
Number of subjects: 50
Study 2321774 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheter with no solution injected
Number of subjects: 50
Study 7359263 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 mg/kg hydrocortisone intravenously every six hours
Number of subjects: 19
Study 7359263 — intervention group
Group type: COMPARATOR
Intervention: Control group (no corticosteroids)
Number of subjects: 19
Study 7359263 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol inhalations and intravenous aminophylline therapy (common to both groups)
Number of subjects: 19
Study 30670044 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote cognitive behaviour therapy (RCBT)
Number of subjects: 156
Study 30670044 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 156
Study 28644208 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) during therapy sessions (S1, S2, S3) consisting of five upper and/or lower extremity exercises.
Number of subjects: 31
Study 28644208 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard therapy alone) during therapy sessions (S1, S2, S3).
Number of subjects: 31
Study 25682816 — intervention group
Group type: EXPERIMENTAL
Intervention: Menstrual Cup (MC)
Number of subjects: 110
Study 25682816 — intervention group
Group type: COMPARATOR
Intervention: Pads/Tampons (Control)
Number of subjects: 110
Study 23982478 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells (MSC)
Number of subjects: 9
Study 23982478 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonrandomized)
Number of subjects: 9
Study 21187202 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight supported treadmill training (BWSTT)
Number of subjects: 6
Study 18984774 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 9795
Study 18984774 — intervention group
Group type: COMPARATOR
Intervention: Control (no fenofibrate)
Number of subjects: 9795
Study 17929488 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 17929488 — intervention group
Group type: EXPERIMENTAL
Intervention: Ftorotan
Number of subjects: 0
Study 15011193 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered advance care planning (PC-ACP) interview for 1 hour
Number of subjects: 27
Study 15011193 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 27
Study 11678967 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg glibenclamide
Number of subjects: 8
Study 11678967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9624786 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking to theatre by ward nurse
Number of subjects: 100
Study 9624786 — intervention group
Group type: COMPARATOR
Intervention: Taken to theatre on a hospital trolley
Number of subjects: 100
Study 7942732 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraductal ultrasound (IDUS)
Number of subjects: 26
Study 7942732 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 26
Study 7942732 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 26
Study 7942732 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic retrograde pancreatography (ERP)
Number of subjects: 26
Study 3146503 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneously breathing group (n=50)
Number of subjects: 98
Study 3146503 — intervention group
Group type: COMPARATOR
Intervention: Artificially ventilated group (n=48)
Number of subjects: 98
Study 3146503 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneously breathing group
Number of subjects: 98
Study 3146503 — intervention group
Group type: COMPARATOR
Intervention: Artificially ventilated group
Number of subjects: 98
Study 31895439 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 2292
Study 31895439 — intervention group
Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 2292
Study 30484987 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Notebook intervention (self-monitoring QOL), completed once daily.
Number of subjects: 200
Study 30484987 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 200
Study 27876083 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment and usual care
Number of subjects: 0
Study 27876083 — intervention group
Group type: COMPARATOR
Intervention: Usual care without endovascular treatment
Number of subjects: 0
Study 25050340 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosaprepitant 150 mg i.v. (NK1 group)
Number of subjects: 64